Man Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Man Group’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-127,723	Closed	-$291K	–	2276
2024 Q2	$291K	Sell	127,723 -147,635	-54%	-$564K	﹤0.01%	1790
2024 Q1	$1.19M	Buy	275,358 +128,692	+88%	+$448K	﹤0.01%	1481
2023 Q4	$447K	Buy	+146,666	New	+$276K	﹤0.01%	1713
2023 Q1	–	Sell	-23,760	Closed	-$114K	–	1912
2022 Q4	$129K	Buy	+23,760	New	+$199K	﹤0.01%	1863
2021 Q2	–	Sell	-11,700	Closed	-$282K	–	2121
2021 Q1	$282K	Sell	11,700 -85,049	-88%	-$1.98M	﹤0.01%	1650
2020 Q4	$1.74M	Buy	96,749 +33,200	+52%	+$496K	0.01%	1250
2020 Q3	$734K	Buy	+63,549	New	+$1.05M	﹤0.01%	1453

Man Group's GTHX Position: Q3 2024 in Review

Man Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 127,723 shares — an estimated $291K sold.

Man Group first reported a position in GTHX in Q3 2020 and held it in 7 quarters. The position peaked at $1.74M in Q4 2020. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Man Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Man Group sold 127,723 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $291K.
Man Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Man Group's G1 Therapeutics, Inc. Common Stock position peaked at $1.74M in Q4 2020.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Man Group's 13F filing for Q3 2024, filed 14 Nov 2024.